Business description: Quest PharmaTech Inc.

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

Sales by Activity: Quest PharmaTech Inc.

Fiscal Period: January 2022 (CAD) 2023 (CAD) 2024 (CAD) 2025 (CAD) 2026 (CAD)

Executive Committee: Quest PharmaTech Inc.

Manager TitleAgeSince
Chief Executive Officer - 16/06/2004
Director of Finance/CFO - 31/12/2004

Composition of the Board of Directors: Quest PharmaTech Inc.

Director TitleAgeSince
Director/Board Member - 16/06/2004
Chairman - 04/07/2021
Director/Board Member - 04/07/2021
Director/Board Member - -

Shareholders: Quest PharmaTech Inc.

NameStocks%Valuation
14.78 %
25,000,000 14.78 % 350 000 $
1.892 %
3,200,000 1.892 % 44 800 $
1.042 %
1,761,518 1.042 % 24 661 $
0.2069 %
350,000 0.2069 % 4 900 $
0 %
0 0 % - $

Company details: Quest PharmaTech Inc.

Quest PharmaTech, Inc.

97 Street NW

T6E 5R9, Edmonton

+

http://www.questpharmatech.com
address Quest PharmaTech Inc.(QPTFF)

Other Biotechnology & Medical Research

Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+5.26%+4.44%+26.03% 51.22B
-1.25%+2.65%+473.19%+600.03% 45.38B
+2.34%+8.96%+20.59%+93.05% 41.97B
+1.08%+9.39%+39.64%+20.77% 42.15B
-0.93%-4.80%+17.39%+46.60% 31.95B
+0.48%+3.11% - - 16.73B
+1.75%+7.24%+36.84%+152.20% 17.1B
+0.03%+3.41%+7.12%+35.49% 14.76B
+1.83%+6.16%+92.38%+47.98% 13.91B
Average +0.69%+3.19%+86.45%+127.77% 30.58B
Weighted average by Cap. +0.60%+3.13%+103.75%+149.46%
  1. Stock Market
  2. Stocks
  3. QPT Stock
  4. QPTFF Stock
  5. Company Quest PharmaTech Inc.